Convalescent plasma treatment of hospitalized patients with COVID-19 has been subject to Emergency Use Authorization (EUA) since August of 2020. Subsequent scientific studies have indicated the need to modify this EUA by limiting use to immunocompromised patients. A...
HHSC recently became aware of an issue causing some claims for the administration of the MenQuadfi vaccine (procedure code 90619) to be denied inappropriately. MenQuadfi is approved by the U.S. Food and Drug Administration for individuals two years of age and older....
Program providers, Financial Management Services Agencies and Consumer Directed Services employers using DataLogic Vesta Windows must start upgrading to Vesta Web. Due to Microsoft ending it’s technical support that Vesta Windows needs, DataLogic will stop using Vesta...
Effective for dates of service on or after March 29, 2022, in accordance with the U.S. Food and Drug Administration amendment to the Emergency Use Authorization, MCOs must add COVID-19 vaccine administration code 0094A for the administration of the booster dose of the...
Effective for dates of service on or after May 17, 2022, in accordance with the U.S. Food and Drug Administration (FDA) amendment to the Emergency Use Authorization (EUA), COVID-19 vaccine administration code 0074A is a benefit of Medicaid and CHIP for the...
